Chaperones News and Research

RSS
CytRx sells global rights of molecular chaperone assets to Orphazyme

CytRx sells global rights of molecular chaperone assets to Orphazyme

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

Protein folding may aid in developing new therapies for brain diseases

Protein folding may aid in developing new therapies for brain diseases

FDA removes clinical hold for Amicus' AT2220 IND for treatment of Pompe disease

FDA removes clinical hold for Amicus' AT2220 IND for treatment of Pompe disease

Amicus to present additional positive data from Amigal Phase 2 extension study for Fabry disease

Amicus to present additional positive data from Amigal Phase 2 extension study for Fabry disease

Acetylation complex fits like a halo over a histone

Acetylation complex fits like a halo over a histone

Scientists discover fundamental mechanism behind toxic protein aggregation in neurodegenerative diseases

Scientists discover fundamental mechanism behind toxic protein aggregation in neurodegenerative diseases

Researchers identify gene mutation for that is essential for correct protein-processing in cells

Researchers identify gene mutation for that is essential for correct protein-processing in cells

Researchers identify new mechanism that could help develop effective chemotherapy drug

Researchers identify new mechanism that could help develop effective chemotherapy drug

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Clusterin associated with development, severity and progression of Alzheimer's disease: Report

Clusterin associated with development, severity and progression of Alzheimer's disease: Report

ADDF awards $210,300 to Amicus Therapeutics to evaluate PCs for treating Alzheimer's disease

ADDF awards $210,300 to Amicus Therapeutics to evaluate PCs for treating Alzheimer's disease

New method helps study interactions needed for formation of lipopolysaccharides

New method helps study interactions needed for formation of lipopolysaccharides

New approach may circumvent lost response in insulin due to obesity

New approach may circumvent lost response in insulin due to obesity

Anesthesia can increase behavioral changes, risk of developing Alzheimer's disease

Anesthesia can increase behavioral changes, risk of developing Alzheimer's disease

Amicus Therapeutics presents additional data from Amigal Phase 2 extension study for Fabry disease

Amicus Therapeutics presents additional data from Amigal Phase 2 extension study for Fabry disease

Anti-inflammatory plant derivative could play a role in cancer treatment, say MCG researchers

Anti-inflammatory plant derivative could play a role in cancer treatment, say MCG researchers

Research offers new hope for rare metabolic disorder

Research offers new hope for rare metabolic disorder

HSF1A stimulates more protein chaperones and reduces protein misfolding

HSF1A stimulates more protein chaperones and reduces protein misfolding

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference